FDA Adverse Event Injury Summary report: N

ONX AORTIC ANATOMIC 21

MDR report key: 12656101 · Received October 19, 2021

Report

Report Number
1649833-2021-00037
Event Type
Injury
Date Received
October 19, 2021
Date of Event
August 24, 2021
Report Date
December 14, 2021
Manufacturer
ON-X LIFE TECHNOLOGIES, INC.
Product Code
LWQ
PMA / PMN Number
P000037
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MN, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Description of Event or Problem · 0

ACCORDING TO THE INITIAL REPORT, ONXAN-21 SN (B)(6) WAS IMPLANTED ON (B)(6) 2016 AND EXPLANTED ON (B)(6) 2021. ADDITIONAL INFORMATION WAS RECEIVED, ONXAN-21 HAD TO BE REMOVED BECAUSE OF PVE (PROSTHETIC VALVE ENDOCARDITIS) IT GOT INFECTED AND THERE WAS A ROOT ABSCESS.

Description of Event or Problem · 1

ACCORDING TO THE INITIAL REPORT, ONXAN-21 SN (B)(4) WAS IMPLANTED ON (B)(6) 2016 AND EXPLANTED ON (B)(6) 2021. ADDITIONAL INFORMATION WAS RECEIVED, ONXAN-21 HAD TO BE REMOVED BECAUSE OF PVE (PROSTHETIC VALVE ENDOCARDITIS) IT GOT INFECTED AND THERE WAS A ROOT ABSCESS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1553071 ONX AORTIC ANATOMIC 21 HEART-VALVE, MECHANICAL LWQ ON-X LIFE TECHNOLOGIES, INC. ONXAN-21

Patients

Seq Age Sex Outcome Treatment
1 51 YR Male Other